VOTE ONLINE
Your vote is IMPORTANT!
Please vote your proxy online now or by phone by
dialing 866-883-7826.
Our report on activities & financial performance throughout the year.
View an enhanced version of information about our annual meeting & matters to be voted upon.
Your vote is IMPORTANT!
Please vote your proxy online now or by phone by
dialing 866-883-7826.
November 30, 2026
12:00 PM ET
You must register in order to attend the virtual meeting.
Turn Therapeutics was founded by Bradley Burnam, Chief Executive Officer, whose experience navigating FDA pathways and building regulated products informs the company’s execution-driven culture.
Under his leadership, Turn Therapeutics is advancing a clear thesis: The future of medicine lies in targeted therapies that work locally, deliver meaningful efficacy, and reduce unnecessary systemic exposure.
Out of that necessity to survive came the foundation of Turn Therapeutics: a company with three FDA cleared medical devices, 15+ patents, and a robust drug pipeline.
Now, Turn Therapeutics is focused on advancing its therapies and mission to increase access to safe and effective medicines.